I. Paul Singh, MD; and Steven R. Sarkisian Jr, MD
Show Description +
Steven R. Sarkisian Jr., MD, joins I. Paul Singh, MD, on Innovation Journal Club to discuss the impact of procedural pharmaceuticals on glaucoma management. Along with a review of a recent study on the topic, the two discuss how the advent of procedural pharmaceuticals enables a more proactive approach.
Posted: 4/01/2025
I. Paul Singh, MD; and Steven R. Sarkisian Jr, MD
Steven R. Sarkisian Jr., MD, joins I. Paul Singh, MD, on Innovation Journal Club to discuss the impact of procedural pharmaceuticals on glaucoma management. Along with a review of a recent study on the topic, the two discuss how the advent of procedural pharmaceuticals enables a more proactive approach.
Posted: 4/01/2025
Supported by
Please log in to leave a comment.